Obesity Pipeline Highlights - 2018

  • ID: 4516371
  • Report
  • Fore Pharma
1 of 3
The latest report Obesity Pipeline Highlights - 2018, provides most up-to-date information on key pipeline products in the global Obesity market. It covers emerging therapies for Obesity in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Obesity pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Obesity pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Obesity pipeline products by the company.

Short-term Launch Highlights:
Find out which Obesity pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:
  • Obesity phase 3 clinical trial pipeline products
  • Obesity phase 2 clinical trial pipeline products
  • Obesity phase 1 clinical trial pipeline products
  • Obesity preclinical research pipeline products
  • Obesity discovery stage pipeline products
  • Obesity pipeline products short-term launch highlights
Note: Product cover images may vary from those shown
2 of 3
1. Obesity Pipeline by Stages
2. Obesity Pipeline by Drug Class
3. Obesity Pipeline by Company
4. Obesity Phase 3 Clinical Trial Insights
5. Obesity Phase 2 Clinical Trial Insights
6. Obesity Phase 1 Clinical Trial Insights
7. Obesity Preclinical Research Insights
8. Obesity Discovery Stage Insights
9. Appendix
10. Research Methodology

List of Tables
Table 1: Obesity Phase 3 Clinical Trials, 2018
Table 2: Obesity Phase 2 Clinical Trials, 2018
Table 3: Obesity Phase 1 Clinical Trials, 2018
Table 4: Obesity Preclinical Research, 2018
Table 5: Obesity Discovery Stage, 2018

List of Figures
Figures 1: Obesity Pipeline Molecules by Clinical Trials Stage, 2018
Figure 2: Obesity Pipeline Molecules by Drug Class, 2018
Figure 3: Obesity Pipeline Molecules by Company, 2018
Figure 4: Obesity Phase 3 Clinical Trial Highlights, 2018
Figure 5: Obesity Phase 2 Clinical Trial Highlights, 2018
Figure 6: Obesity Phase 1 Clinical Trial Highlights, 2018
Figure 7: Obesity Preclinical Research Highlights, 2018
Figure 8: Obesity Discovery Stage Highlights, 2018
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll